Stem cell therapy for severe viral pneumonia
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether injecting stem cells from the womb's blood supply can help treat severe viral pneumonia. It aims to improve recovery for people who are very sick and need hospital care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You have severe pneumonia caused by a virus (other than COVID-19) that requires hospital care.
- You do not have any active cancer or pre-cancerous conditions.
- You are not currently on a heart-lung bypass machine (ECMO).
- You are not taking strong immune-suppressing drugs like high-dose steroids or chemotherapy.
- You are not pregnant, breastfeeding, and agree to use effective birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an injection of stem cells from umbilical cords can help people with severe ARDS (a type of lung failure) recover faster. It is for those who have not improved after standard treatment and whose ARDS is caused by an infection (not COVID-19).
This trial tests a new approach combining a traditional Chinese medicine formula with bacteriophages (viruses that attack bacteria) to treat severe pneumonia caused by antibiotic-resistant bacteria. It aims to see if this combination can improve outcomes for patients who have limited treatment options.
This trial studies whether a new treatment using stem cells from healthy donors can help people with severe or critical COVID-19. The goal is to see if it reduces inflammation and helps you recover faster.
This study tests a new treatment made from small mobile stem cells, given by inhalation, for people with moderate to severe COPD caused by smoking or pollution. It aims to see if the treatment is safe and helps improve lung function.
This trial tests a Chinese herbal formula combined with virus-based therapy (bacteriophages) to treat severe pneumonia caused by antibiotic-resistant bacteria. It may offer a new option when standard antibiotics fail.
This trial tests whether a special stem cell treatment can help people with moderate to severe COPD when regular medicines are not working well. The treatment may reduce breathing problems and improve quality of life.
Hear when a new Severe Viral Pneumonia(Not Include COVID-19) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.